CLDI stock rated a Buy by H.C. Wainwright

Calidi Biotherapeutics Inc’s filing revealed that its Director Schoeneck James A acquired Company’s shares for reported $0.15 million on Aug 21 ’25. In the deal valued at $2.00 per share,75,000 shares were bought. As a result of this transaction, Schoeneck James A now holds 76,134 shares worth roughly $0.13 million.

Then, Poma Eric E bought 25,000 shares, generating $50,000 in total proceeds. Upon buying the shares at $2.00, the Chief Executive Officer now owns 25,000 shares.

Before that, Leftwich Scott bought 125,000 shares. Calidi Biotherapeutics Inc shares valued at $250,000 were divested by the Director at a price of $2.00 per share. As a result of the transaction, Leftwich Scott now holds 130,650 shares, worth roughly $0.22 million.

H.C. Wainwright initiated its Calidi Biotherapeutics Inc [CLDI] rating to a Buy in a research note published on November 22, 2023; the price target was $11. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating.

Price Performance Review of CLDI

On Tuesday, Calidi Biotherapeutics Inc [AMEX:CLDI] saw its stock jump 8.97% to $1.7. Over the last five days, the stock has lost -43.33%. Calidi Biotherapeutics Inc shares have fallen nearly -90.16% since the year began. Nevertheless, the stocks have fallen -87.68% over the past one year. While a 52-week high of $46.68 was reached on 07/09/25, a 52-week low of $1.54 was recorded on 08/25/25.

Levels Of Support And Resistance For CLDI Stock

The 24-hour chart illustrates a support level at 1.6200, which if violated will result in even more drops to 1.5400. On the upside, there is a resistance level at 1.8300. A further resistance level may holdings at 1.9600.

How much short interest is there in Calidi Biotherapeutics Inc?

A steep rise in short interest was recorded in Calidi Biotherapeutics Inc stocks on 2025-08-15, dropping by 19342.0 shares to a total of 0.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 0.29 million shares. There was a decline of -7.16%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.